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Abstract
Background: Dioxins are one of the most toxic groups of persistent organic pollutants. Their bioaccumulation
through the food chain constitutes a potential risk for human health. Upon cell entry, dioxins bind specifically and
firmly to the aryl hydrocarbon receptor (AhR), leading to the stimulation of several enzymes responsible for its
detoxification. Dioxin/AhR interaction could be exploited as an affordable alternative to a variety of analytical
methods for detecting dioxin contamination in the environment.
Results: In this work, the ligand binding domain (LBD) of the AhR was cloned downstream a superfolder form of
the green fluorescent protein (sfGFP), resulting in the construct pRSET-sfGFP-AhR. High level of expressed sfGFP-AhR
fusion protein (50 kDa) was recovered from the inclusion bodies of E. coli by simple solubilization with the Arginine,
and purified by affinity chromatography via its N-terminal 6 × His tag. Its purity was confirmed by SDS-PAGE analysis
and immunoblotting with anti-His or anti-GFP antibodies. Indirect ELISA revealed the ability of the sfGFP-AhR, but
not the sfGFP, to bind to the immobilized dioxin with the possibility to detect such interaction by both its 6 × His
and GFP tags,Competitive ELISA showed that anti-dioxin antibody was more sensitive to low dioxin concentrations
than sfGFP-AhR. Nevertheless,the detection range of sfGFP-AhR fusion was much wider and the detection limit was
of about 10 ppt (parts per trillion) of free dioxin in the tested artificial samples.
Conclusions: this highly expressed and functional sfGFP-AhR fusion protein provides a promising molecular tool for
detecting and quantifying different congeners of dioxins.
Keywords: TCDD, sfGFP, AhR, Protein expression, Fusion proteins, Cloning
Background
Collectively termed as dioxins, polychlorinated dibenzo-
p-dioxins (PCDDs) and polychlorinated dibenzofurans
(PCDFs) are the most toxic group of the persistent or-
ganic pollutants (POPs). Depending on the chlorination
level (P = 1–8), dioxins form a generic group of 75
PCDD congeners and 135 PCDF congeners with varying
degrees of toxicity. The congeners with chlorine atoms
substituted in the lateral 2, 3, 7 and 8 positions of the
aromatic rings are considered as the most toxic.
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD), with a
toxic equivalency factor (TEF) of 1.0, is the most toxic
congener of dioxins [1]. Consequently, TCDD was
used as a good candidate for investigations of the
physiological and toxicological effects of this class of
chemicals [2, 3].
Dioxins are a major product of industrial, municipal
and domestic incineration and combustion processes [4]
and during industrial processes involving chlorinated
aromatic and aliphatic compounds, such as pesticides
and herbicides synthesis [5]. Currently, incineration of
the solid wastes contributes the most to the release of
these compounds into the environment [6].
Due to their persistence and high lipophilicity, PCDD/Fs
are subject to lipophilic bio-concentration and accumula-
tion in the food chain [7]. Their adverse health effects are
now well reported; for example the wasting syndrome [2],
immunotoxicity [8], teratogenicity [3], dysfunctional im-
mune and reproductive systems [9] and carcinogenesis
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[10]. An effective and serious contamination with dioxins
has been previously reported in soils, sediments, air and
water [11, 12]. In this context, numerous analytical
techniques have been developed for the detection and
quantification of dioxins. High resolution gas chromatog-
raphy combined with high resolution mass spectrometry
(HRGC/HRMS) is considered the most reliable and
sensitive method for separation, identification and deter-
mination of the congener-specific concentrations of dioxins
[13]. However, this technique requires a sophisticated
platform and highly trained personnel, besides being very
costly and time-consuming. Consequently several rapid
and inexpensive screening assays have been proposed.
Immuno-detection, which depends on the ability of a
certain compound to be precisely recognized and bound by
a specific antibody, makes the base of what is known as the
enzyme-linked immunosorbent assay (ELISA) [14, 15].
Alternatively, the detection of signal transduction effects
that are related to dioxin stimulation in vitro or in cells has
been exploited using sophisticated methods; such as the
chemical activated luciferase gene expression (CALUX)
system [13].
The biological effects of the dioxins in the body
critically depend on a cytosolic protein, the aryl hydro-
carbon receptor (AhR) [16]. The AhR resembles nuclear
receptors (among which it was initially categorized)
acting as a ligand-activated transcription factor [16]. In
response to activation by dioxins, AhR signalling path-
way modifies the expression levels of numerous genes.
The best characterized of these pathways at the molecular
level is that leading to the induction of the gene for a
Phase I drug-metabolizing enzyme; CYP1A1 [17]. In the
dormant state, the AhR resides in the cytosol in a protein
complex also containing a dimer of heat shock protein 90
(HSP90), an AhR-associated protein-9 and p23 [18]. These
chaperone proteins stabilize the AhR maintaining it in a
conformation that is unable to enter the nucleus but
optimal for ligand binding [19]. The AhR then dissociates
from the chaperones and heterodimerizes with the AhR
nuclear translocator (ARNT) [20]. AhR/ARNT dimer
binds to the major groove of the DNA helix at specific
sites [21]. Structurally, the AhR belongs to basic
Helix–Loop–Helix/Periodic, AhR nuclear translocator,
single-minded (bHLH/PAS) proteins. The AhR contains
several important structural elements; including an
N-terminal bHLH domain, a C-terminal transcriptional
activation domain and a central PAS domain containing
two degenerated repeats (PAS-A and PAS-B). The ligand
binding domain (LBD) of the AhR is localized between
amino acids 230 and 397 [22], and has a similar affinity
for TCDD binding as the full-length AhR [23].
In line of these insights we investigated the possibility
to fuse the LBD of the AhR with a marker protein, the
green fluorescent protein (GFP), in order to exploit the
resulting recombinant fusion protein in dioxins detec-
tion. The GFP from Aequorea jellyfish is widely used as
an excellent expression tag for several fusion proteins
[24], and it has been expressed in a variety of species;
including bacteria, plants, Drosophila melanogaster,
Caenorhabditis elegans, zebrafish, andmammals [24–26].
Waldo and co-workers reported the engineering of an
enhanced superfolder (sf ) form of the GFP, and this
sfGFP showed increased resistance to denaturation,
improved folding kinetics, and increased resistance to
aggregation during protein expression [27]. Therefore,
the main objective of the current study was to express
the sfGFP-AhR fusion protein in E. coli. Computational
3D structure prediction of this fusion suggested a total
accessibility of the AhR moiety for TCDD binding, and
consequently this was confirmed in our immunological
experiments. Optimized sfGFP-AhR fusion could effect-
ively be invested in as an affordable, rapid, sensitive and
environment-friendly technique to detect the presence of
dioxins in environment samples and food commodities.
Methods
Preparation of the AhR cDNA from HepG2 cell line
Total RNA was extracted from the human hepatoma
cells (HepG2) using IllustraRNAspin Mini Kit (GE Life
Sciences) according to the manufacturer's manual. 2 μg
of the RNA was reverse-transcribed to the cDNA using
Ready-to-Go You-prime first-strand-beads (GE Life
Sciences) with oligo-dT15–18 (Invitrogen). 2 μl of the
cDNA was used as a template in a PCR with a pair of
specific primers for the AhR(LBD); AhR(BamHI)-F and
AhR(EcoRI)-R (Additional file 1: Table S1). Primers were
designed to amplify the LBD of the AhR gene and to add
BamHI and EcoRI restriction sites at the 5' and 3' ends,
respectively. The fragment of LBD was amplified by a
high fidelity Taq DNA polymerase (AccuPrime™ Kit;
Invitrogen) at 55 °C annealing temperature. Amplified
AhR fragment and the pRSET-sfGFP plasmid [28] were
digested with BamHI and EcoRI (Fermentas) then ligated
using the T4 DNA ligase following standard procedures
(Fermentas).
Bacterial strains and growth conditions
E. coli strains TOP10 (Invitrogen) and BL21(DE3) Gold
(Novagen) were used in cloning and protein expression.
E. coli was grown in Luria Broth (LB; 1 % Tryptone,
0.5 % yeast extract, 171 mM NaCl) (Bio Basic Inc.) with
ampicillin antibiotic (100 μg/ml, Sigma) in orbit-rotating
incubator at 37 °C. Freshly prepared electro-competent
E. coli TOP10 cells were transformed with the plasmid
constructs by electroporation. Colony PCR screening for
positive AhR clones was performed using pRSET specific
primers (T7F/T7R) (Additional file 1: Table S1). The
plasmid constructs were isolated from some positive
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clones by plasmid Miniprep Kit (Qiagen) after being
grown in LB/ampicillin medium. The identity of these
plasmid constructs was confirmed by digestion with
the restriction enzymes and by sequencing using dif-
ferent sequencing primers covering the full-length
LBD (Additional file 1: Table S1).
Expression of the sfGFP-AhR fusion protein as inclusion
bodies
The confirmed plasmid constructs; the pRSET-sfGFP
and pRSET-sfGFP-AhR, were used to transform E. coli
BL21 (DE3) Gold cells by electroporation. Protein ex-
pression was performed in 250 ml shake flasks by grow-
ing the bacteria in LB medium till an optical density of
0.5 to 0.7 was reached, and then the expression was in-
duced with 0.5 mMIsopropylthio-D- galactoside(IPTG,
Promega) for 16 h at 15 °C. After centrifugation, the pel-
let of bacteria was resuspended on the binding buffer(50
mMtris-HCl pH 8.0, 150 mM NaCl and 1 mMphenyl-
methylsulfonyl fluoride (PMSF, Sigma) supplemented
with a complete protease inhibitor cocktail (Roche), then
lysed by 8 pulses (15 s each) of sonication at 22 % ampli-
tude (750-Watt Ultrasonic Homogenizer, Cole-Parmer)
in ice. The lysate containing soluble proteins as the
sfGFP was cleared by centrifugation at 12000 × g for
20 min at 4 °C. The pellet of the inclusion bodies con-
taining insoluble proteins (as the sfGFP-AhR) was re-
suspended by sonication in the same binding buffer
supplemented with (5 mM DTT, 5 mM EDTA, 1 M
urea and 1 % triton-x). This washing step is designed
to remove contaminants, especially proteins that may
have adsorbed onto the hydrophobic inclusion bodies
during processing and could affect protein refolding
yield. After washing with the basic binding buffer to
eliminate the detergents, inclusion bodies were ready
to be solubilized using the different reagents.
Refolding and solubilizion of sfGFP-AhR inclusion bodies
To assess the optimal reagent for assisting the correct
refolding of the sfGFP-AhR, inclusion bodies were pre-
pared at 0.1 mg/ml TBS buffer (20 mMtris-HCl pH 8.0
and 150 mM NaCl). 500 μl of this preparation was dis-
tributed into several 1.5 ml microtubes then centrifuged
at max speed for 5 min. The pellets in the microtubes
were dispersed and dissolved by sonication in the same
buffer containing different concentration of various
additives reported in the literature [29] (Additional file 2:
Table S2). After 30 min of incubation at RT, supernatant
(soluble fraction) was recovered from each condition by
centrifugation and the remaining pellet of insoluble
sfGFP-AhR was dissolved by sonication in 500 μl of 8 M
urea-containing buffer (insoluble fraction). The formation
of a fluorophore in the soluble and insoluble fractions
was monitored by measuring the fluorescence density,
expressed as a relative fluorescent unit (RFU), at excitation
wavelength 485 nm with emission wavelength 538 nm
(Fluoroskan Ascent, Thermo Labsystems), and the fluoro-
phore fluorescein (Sigma) was used as a control.
Purification of the sfGFP and sfGFP-AhR fusion proteins
Soluble fractions of E. coli extract containing the sfGFP
and Arginine-refolded sfGFP-AhR were dialysed in bind-
ing buffer containing 20 mM imidazole and then purified
using a 5 ml column of nickel charged nitrilotriacetic acid
(NTA) superflow sepharose (Qiagen) installed on the fast
protein liquid chromatography (FPLC) AKTA prime plus
system (GE Life Sciences). After washing, bound proteins
were eluted from the column with 500 mM imidazole-
containing buffer. The eluted fraction was concentrated
on Vivaspin concentrators with a molecular mass cut-off
of 10 kDa (Vivascience). The concentration of the purified
proteins was determined by the Bradford method, and
their purity was evaluated in SDS-PAGE prepared using
stacking gel 5 % and running gel 12 %. After electrophor-
esis, the gel was stained in coomassie brilliant blue buffer
(45 % methanol, 10 % acetic acid and 0.25 % coomassie
R250) for 2 h and then washed several times in the
destaining buffer.
Immunoblotting of the sfGFP and sfGFP-AhR
Purified proteins were separated by SDS-PAGE before
blotting onto 0.45 μm nitrocellulose membranes (Bio-
Rad) using 1× transfer buffer (25 mMtris-HCl, 200 mM
glycine, 0.1 % SDS and 20 % methanol). After blotting,
the membranes were washed with TBS-T (0.05 %
Tween-20 in TBS) then incubated in the blocking buffer
(5 % skimmed milk in TBS-T). The membranes were in-
cubated with 1:2000 dilution of either mouse anti-GFP
(Roche) or mouse anti-6 × His (R&D Systems) antibodies
for 1 h at RT. After several washes with TBS-T, the
membranes were incubated with (1:2000) dilution of a
secondary goat anti-mouse antibody conjugated to the
horseradish peroxidase (HRP, Bethyl laboratories) for 1 h
at RT. Bands revelation was achieved by adding 3-amino-
9-ethylcarbazole (AEC, Sigma) chromogen substrate in
acetate buffer in the presence of a hydrogen peroxide.
Indirect ELISA assay for testing sfGFP-AhR
An indirect ELISA was performed by immobilizing the an-
tigens (10 nM), sfGFP-AhR or sfGFP, on a standard Maxi-
Sorp 96-well plate (Nunc) overnight in a bicarbonate/
carbonate coating buffer (100 mM, pH 9.6). Alternatively,
dioxin binding was tested using a TCDD-pre-coated 96-
well ELISA microplate (Abraxis LLC). Before use, all
different plates were incubated in the blocking buffer (5 %
skimmed milk in TBS-T) for 2 h at RT then washed 3
times with TBS-T. Immobilized TCDD in the wells was
directly detected using a rabbit-anti-TCDD (Abraxis),
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following the manufacturer's instructions. Otherwise, the
sfGFP-AhR and sfGFP were diluted to the desired concen-
tration (100 nM) in 1 % blocking buffer then applied to
the wells (100 μl) for 16 h at 4 °C, then washed 3 times
with TBS-T. Antigens (immobilized or bound to TCDD)
were detected by an incubation for 1 h at RT with a
diluted (1:2000) mouse anti-6 ×His, rabbit anti-6 × His
(Bethyl laboratories), mouse anti-GFP or rabbit anti-GFP
(a homemade product, [28]). After 5 washes, diluted
(1:2000) goat anti-mouse or goat-anti-rabbit IgGs conju-
gated to horseradish peroxidase (HRP, Bethyl laboratories)
were added to the appropriate wells. The wells were then
washed 5 times before bound conjugates were detected
with 50 μl of 3,3′,5,5′-tetramethylbenzidine (TMB, Sigma)
ready-to-use substrate. The reaction was finally stopped
with the addition of 50 μl of 1 M H2SO4. The spectroscopic
absorbance of each well was measured in an automated
plate reader at a wavelength of 450 nm.
TCDD detection by a competitive indirect ELISA using the
sfGFP-AhR
Using the same TCDD-pre-coated plates and doing the
same primary steps of blocking and washing, the com-
petitive ELISA was carried out by incubating the sfGFP-
AhR (30 nM) or rabbit-anti-TCDD with serial dilutions
(from 0 – to 100,000 parts per trillion (ppt) in 1 %
DMSO-containing blocking buffer) of free TCDD (stock
at 10 μg/ml, purity 99 %, Supelco Inc.) in 100 μl volume
for 2 h at RT. Different conditions were then transferred
to TCDD-pre-coated wells and incubated for further 2 h
at RT. The following steps were performed as described
earlier using a rabbit-anti-GFP antibody, goat-anti-
rabbit-HRP and the TMB substrate. The experiments
were performed three times to determine the mean
values (used to draw the graphs) and the error bars were
calculated by dividing the standard deviation of the data
by the square root of number (3) of values that make up
the mean.
Results
Design of the sfGFP-AhR fusion protein
Human AhR is a relatively large protein of 96 kDa
composed of 848 amino acids (aa), extending over
several well identified functional domains (Fig. 1a). LBD
positioned from 231 to 428 was cloned downstream of the
sfGFP gene in the plasmid pRSET-sfGFP, resulting in a fu-
sion protein of 50 kDa (Fig. 1a). The resulting sfGFP-AhR
fusion protein contains an N-terminal 6 × His-tag and a
free and flexible LBD moiety exposed an internal polypep-
tide linker GGSSSG at its C-terminal (Fig. 1a). A soluble
cytoplasmic N-terminal 6 ×His-tagged sfGFP of 27 kDa
was also expressed in E. coli using the original plasmid
pRSET-sfGFP (Fig. 1a) [28, 30]. A simple 3D-modeling of
the cloned LBD showed the cavity for TCDD binding that
extends from 284 to 390 aa, overlapping entirely with the
PAS-B domain and containing several aa whose side
chains are critical for TCDD binding. These aa are found
to be highly conserved between human, mouse and rat as
well as many other mammalian species [31], and the main
secondary structures (the alpa-helixes and the beta-chain
strands) of the cavity are also conserved (Additional file 3:
Figure S1). As inferred from the 3D structure predic-
tion of the fusion protein, this cavity appeared to be
exposed away from the sfGFP and in a favourable
orientation for TCDD binding (Fig. 1b, Additional file 1:
Table S1).
Cloning of AhR gene into the pRSET-sfGFP plasmid
The AhR(LBD) was amplified from the cDNA of the
HepG2 cell line using a couple of AhR-specific primers,
and a single DNA fragment of 630 bp was therefore ob-
tained and cloned in the pRSET-sfGFP plasmid (Fig. 2a).
After transformation in E. coli, positive colonies were se-
lected and used for plasmid mini-preparation and the
correct constructs were verified by BamHl/EcoRI-digestion
(Fig. 2b). An expected band of 609 bp corresponding to the
LBD fragment was only resulted from digesting the
construct pRSET-sfGFP-AhR and not the original plas-
mid (Fig. 2b). Furthermore, the cloned insert in the
pRSET-sfGFP-AhR was entirely sequenced and aligned to
the human AhR gene sequence (Accession: NM_001621)
to confirm the absence of mutations.
Plasmids like the pRSET with a T7 promoter are widely
used for high throughput protein expression in E. coli
strains carrying the lambda DE3 lysogen [32] (Additional
file 4: Figure S2 and Additional file 2: Table S2).
Expression of the fluorescent sfGFP-AhR fusion protein
Expression of the sfGFP-AhR was carried out after
transformation of E. coli BL21 (DE3) Gold cells with the
confirmed pRSET-sfGFP-AhR construct. A remarkable
expression of a 50 kDa green sfGFP-AhR fusion protein
was observed after IPTG induction. Unexpectedly, the
expressed sfGFP-AhR was mainly accumulated in the
form of the inclusion bodies, and a small amount of the
protein was foundsoluble in the cytoplasm (Fig. 3a).
Fluorescence properties of the sfGFP-AhR fusion pro-
tein, recovered from the inclusion bodies by solubilizing
in urea, were investigated using serial concentrations.
Apparently, the sfGFP-AhR exhibited a fluorescence, but
to a lesser extent than the sfGFP, at a standard wave-
length for excitation (485 nm) and emission (538 nm)
(Fig. 3b). However, fluorescence spectra of the free
and fusion sfGFP seemed to be identical at several
pairs of wavelengths for excitation and emission and
differ slightly from the spectrum of the fluorescein
(Fig. 3b, inset).
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Optimization of in vitrosfGFP-AhR refolding
Due to the insolubility of the expressed AhR-sfGFP fu-
sion, an in vitro solubilizing and refolding process was
required to obtain an active form of the protein. Several
reagents were added into the buffer of the inclusion
bodies to improve the solubility and prevent the aggrega-
tion of the sfGFP-AhR protein as described in Materials
and Methods. By comparing the fluorescence in soluble
and insoluble fractions, only three reagents (0.4 M
Arginine, 0.1 M Lauroylsarcosine and 0.1 % SDS) were
able to to solubilize the inclusion bodies completely, and
no remaining fluorescence could be detected in the
insoluble fraction (Fig. 4a). Other used reagents were not
as effective as these three conditions in solubilizing the
sfGFP-AhR. Next, serial concentrations of Arginine (from
0 to 0.4 M) and Lauroylsarcosine (from 0 to 0.08 M) were
examined for optimizing the solubilization of sfGFP-AhR
inclusion bodies. As we did before, the fluorescence of
the sfGFP-AhR was measured in soluble and insoluble
fractions. Effectively, protein solubility was enhanced
using increasing concentrations of both reagents
(Fig. 4b and c). Consequently, 0.1 M Arginine was
Fig. 1 Designing of the sfGFP-AhR fusion protein. a Schematic representation of the hAhR gene and the two recombinant proteins; sfGFP-AhR and
sfGFP, used in this study. The different domains of the AhR gene are shown and the cloned LBD domain (231–428 aa) is indicated. The theoretical
molecular size (kDa) and molecular weight (pMoles/μg) are shown to the right of each recombinant construct. Positions of the different elements;
6 × His tag, GGSSSG linker and glycosylation sites, are indicated using specific symbols ●, ♦ and *, respectively. b Cartoon representation of the
modelled 3D structure of the sfGFP-AhR fusion, where TCDD binding cavity and the N-terminal 6 × His tag are shown. Structure simulation was
predicted using Phyre2 server [47]
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used for refolding and solubilizing of the sfGFP-AhR
fusion from the inclusion bodies.
Purification and immunodetection of the sfGFP-AhR
Purification of the sfGFP-AhR from the solubilized in-
clusion bodies was performed on an immobilized-metal
affinity chromatography using Nickel-charged NTA
column (Fig. 5a). The integrity of the purified proteins,
the sfGFP-AhR and sfGFP, was analysed by SDS-PAGE
and immunoblotting by either mouse anti-GFP or anti-
6 × His antibodies. Two major specific bands of about 50
and 27 kDa, corresponding to the sfGFP-AhR and sfGFP,
respectively, were immune-detected on the membranes
(Fig. 5b). The purified sfGFP-AhR and sfGFP were tested
in a solid-phase ELISA through targeting their GFP and
6 × His tags using different monoclonal and polyclonal
antibodies. Obviously, the GFP tag allowed much more
efficient detection of both ELISA-immobilized proteins
compared to the 6 × His tag, and this could be related to
the great differences in the size and epitopes availability
of these two tags (Fig. 5c). These data indicated clearly
that the immunodetection of the sfGFP-AhR fusion
could be achieved efficiently using specific anti-GFP
antibodies.
Detection of the interaction of the sfGFP-AhR with dioxin
The sfGFP-AhR was effectively able to detect the immo-
bilized TCDD using either anti-6 × His or anti-GFP anti-
bodies (Fig. 6a and b). However, the major absorbance at
450 nm (about 1.4) was detected in the case of anti-GFP,
Fig. 3 Expression of the fluorescent sfGFP-AhR. a SDS-PAGE (acrylamide
12 %) separation of protein samples obtained after the expression of the
sfGFP-AhR, showing total cell extract before (lane 1) and after 16 h
(lane 2) of IPTG induction, soluble fraction (lane 3) and the lysate of the
inclusion bodies in 8 M urea (lane 4). Detection of migrated proteins
was done by a coomassie blue staining. b Fluorescence of serial
concentrations of the sfGFP and sfGFP-AhR was measured at the
wavelength 485 nm for excitation (EX) and 538 nm for emission (EM).
The values were expressed as a relative fluorescent unit (RFU) and the
accuracy is shown next to each curve (R2). (Inset) Fluorescence spectra
of the different proteins (30 μg/ml) and the fluorophore fluorescein
(1 μg/ml) were determined by measuring RFU at available pairs of
wavelengths on the Fluoroskan Ascent® microplate reader. Blank
conditions represent the fluorescence of PBS-containing wells
Fig. 2 Construction of the pRSET-sfGFP-AhR plasmid. a PCR
amplification was performed on the cDNA of HepG2 cells and the
products were separated on a 1 % agarose gel; a fragment (265 bp)
of actin gene as a control (lane 1), small domain from the AhR gene
using internal primers (lane 2) and the full-length of LBD (lane 3).
Expected sizes of the amplified bands are shown to the right. b
1 % agarose gel containing the pRSET-sfGFP-AhR (lanes 1&2) and
pRSET-sfGFP (lanes 3&4); undigested (lanes 1&3) or digested with
BamHI/EcoRI restriction enzymes (lanes 2&4). The extracted AhR
insert is indicated with an arrow to the right
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and the sfGFP was used as a negative control (Fig. 6b).
As a positive control, the immobilized TCDD gave an
absorbance of 0.8 when detected using specific anti-
TCDD (a-TCDD) antibody. Competitive ELISA is usu-
ally used as an analytical method to quantify dioxins in
food, feed and environmental soil samples. The principle
of the competitive ELISA is that free dioxins in the sam-
ples compete with the immobilized dioxin for binding to
the detecting molecule (sfGFP-AhR or a-TCDD). There-
fore, we used this system of detection to confirm the
sensitivity of the sfGFP-AhR fusion towards TCDD. For
this purpose, we firstly determined the optimal effective
concentration of the sfGFP-AhR necessary for achieving
75 % of the maximal detection of the immobilized
TCDD (EC75 = nM). To do that, serial logarithmic molar
concentrations of the sfGFP-AhR were incubated in the
wells of TCDD-pre-coated microplate then the binding
activity was evaluated using a rabbit-anti-GFP antibody.
A linear correlation between the absorbance and the
concentrations of the sfGFP-AhR was clearly observed,
and EC75 of the detection was estimated to be about
33.1 ± 9.2 nM (Fig. 7a). Based on this data, a sfGFP-AHR
concentration of 30 nM was subsequently used. Differ-
ent concentrations of TCDD (in ppt) were incubated
with either the sfGFP-AhR or a-TCDD, and then added
into the wells of the TCDD-pre-coated microplate. Bind-
ing of the detecting molecule to immobilized TCDD was
finally revealed by the secondary antibodies. Absorbance
values were inversely proportioned to the amount of free
TCDD in the samples. In the case ofthea-TCDD, EC50 of
the detection was 11.9 ± 0.4 ppt and the detection range
(from EC99 to EC1) was from 1.1 ± 0.05 ppt to 83.7 ±
2.6 ppt, whereas the sfGFP-AhR showed a higher EC50
of about 346.5 ± 21.4 ppt with a wider detection range
from 0.8 ± 0.04 ppt to 51600 ± 15500 ppt (Fig. 7b). In
conclusion, the sum of dioxin in the target samples
could be detected using a similar method and its exact
concentration could be calculated by a comparison with
the same standard curve and logarithmic fit equation.
Discussion
To date, many reports have described the heterologous
expression of the recombinant AhR in both prokaryotic
and eukaryotic cell types. Particularly, the recombinant
expression of the ligand-binding competent AhR would
have significant advantages for many bioanalytical appli-
cations regarding dioxins detection. The majority of the
described methods take advantage of the ability of
dioxin/AhR complexes to trigger certain signal transduc-
tion pathways [33]. Transgenic tobacco plants carrying
Fig. 4 Optimization of the in-vitro sfGFP-AhR refolding. a Several additives were added at their indicated optimal concentration to solubilize a
pellet (0.1 mg in 1 ml) of sfGFP-AhR inclusion bodies (soluble fraction). Remaining insoluble precipitates were recovered by centrifugation and
solubilized in 8 M urea (insoluble fraction). Serial molar concentrations of Lauroylsarcosine (b) and Arginine (c) used for solubilizing the pellet of
sfGFP-AhR inclusion bodies. The RFU was measured (EX: 485/EM: 538) in soluble and insoluble fractions for each additive and for the different
concentrations of the last two additives
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the recombinant mouse AhR-mediated β-glucuronidase
(GUS) reporter gene expression system was designed and
showed a significantly increased GUS activity when
treated with certain AhR ligands [34]. Such assays did not
need any extraction and purification of chemicals and
seemed to be useful for a biochemical assay of dioxins and
dioxin-like compounds [35]. Furthermore, recombinant
yeast cells Saccharomyces cerevisiae have been designed as
a dioxin bioassay system, in which the expressed full
length human or mouse AhR/Arnt complexes form after
ligand binding and interact with a responsive element lo-
cated on the promoter of ß-galactosidase reporter gene
[36], and this system was utilized to identify potent en-
dogenous AhR ligands from human urine and bovine
serum [37]. Baculovirus expression vector system was uti-
lized for high level production of the full-length human
and rat AhR in Spodopterafrugiperda (Sf9), and the re-
combinant proteins were active in the quantitative analysis
of the ligand [38]. In fact, the absence of the disulfide brid-
ges and glycosylation sites in the LBD of AhR makes it a
more suitable target for expression in E. coli. However,
several attempts for LBD expression in E. coli were unsuc-
cessful because of its instability and its high tendency to
aggregate because of misfolding or incomplete folding
processes [23]. Therefore, fusion protein technology is
considered one of the best solutions to enhance the pro-
tein expression and solubility. For example, it chaperones
the proper folding, facilitates the purification and reduces
the protein degradation or toxic effects [39]. Many fusion
moieties are available to improve the expression and
Fig. 5 Purification and characterization of the sfGFP-AhR. a Diagram
of the purification procedure using Ni+-NTA column installed on
FPLC AKTA prime system. Continuous line represents the absorbance
of the eluate, and the peaks of the flow-through sample and purified
protein (sfGFP-AhR) are indicated. Dashed line represents conductivity
of the eluate. b Detection of the purified sfGFP and sfGFP-AhR was
done after SDS-PAGE separation either by blue staining or by immune
blotting using anti-GFP or anti-6 × His antibodies. The protein
molecular weight ladder is in the first lane (M). c Indirect ELISA for
testing the purified sfGFP-AhR and sfGFP that were immobilized
(10nM) on the microplate and detected by polyclonal and monoclonal
anti-GFP or anti-6 × His tag antibodies (1:2000)
Fig. 6 Testing the interaction of the sfGFP-AhR with the TCDD by
ELISA Indirect ELISA was performed using TCDD-pre-coated microplate.
Anti-TCDD, sfGFP-AhR (100 nM) and sfGFP (100 nM) were added to the
wells and the interaction was detected either by an anti-6 × His (a) or
anti-GFP (b) antibodies. The graphical inset in each panel explains the
principle of the detection method
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purification of proteins, including glutathione S-transferase
(GST), maltose-binding protein (MBP), thioredoxin A
(TrxA), and the GFP [40].
In the current study, we successfully produced the LBD
of AhR in a fusion with the sfGFP, resulting in its expres-
sion at a high level (~150 mg/L of bacteria culture) in the
cytoplasm of E. coli. Despite its well documented stability
and solubility, the enhanced form of the GFP, the super-
folder GFP, failed to maintain the correct folding of the
expressed AhR, leading therefore to its accumulation into
the inclusion bodies. This was disappointing since many
reports described the recovery of several insoluble pro-
teins from the inclusion bodies simply by their merging
with the sfGFP, e.g. the human growth hormone [41], and
in certain cases, this resulted in the enhancement of their
physiological roles [42]. The culture and induction condi-
tions, including temperatures and IPTG concentrations,
may play a critical role in the solubility of many recombin-
ant proteins, especially, when some stringent culture con-
ditions provoke the production of large quantities of the
exogenous protein that the cell folding machinery fails to
process [43]. Hence, several conditions were tested to as-
sess their influence on the solubility of the sfGFP-AhR
which was simply monitored by comparing the colour of
the bacterial lysate and precipitate. Unfortunately, the fu-
sion greenish protein was always found in the inclusion
bodies regardless of the conditions used, even with the
mild ones; Tm 10 °C and 0.1 mM IPTG, on the contrary,
free sfGFP was always soluble when expressed from the
plasmid pRSET-sfGFP, using many different culture condi-
tions (data not shown).
Arginine has long been used as an interesting additive
for solubilizing the inclusion bodies and enhancing pro-
tein solubility and stability [44]. Its mechanism of action
relies on inhibiting the aggregation of misfolded proteins
and surrounding their exposed hydrophobic surfaces.
Furthermore, 0.5–2MArginine, can be used to actively
extract the folded proteins from insoluble pellets ob-
tained after lysing E. coli cells [44]. Comparing several
tested solubilizing reagents reported in the literature
[29], we found that low concentrations of Arginine, e.g.
0.1 M, were enough to refold totally sfGFP-AhR from
the inclusion bodies, and even without a prior step for
solubilizing the inclusion bodies in 6 M guanidine-HCl
or 8 M urea. Lauroylsarcosine showed a similar effect on
the inclusion bodies of the sfGFP-AhR, however its se-
verity, as a strong ionic detergent, compared to the Ar-
ginine which is barely a stabilizing amino acid, makes its
uses unfavourable in the production procedure of the
sfGFP-AhR. Nevertheless, we speculated from this ex-
periment that the structure of the sfGFP-AhR is moder-
ately misfolded, making its recovery from the inclusion
bodies an easy and inexpensive task to perform. This
could be related to the sfGFP owing to the folding repu-
tation it has, beside, its visible and florescent signals
which made it possible to track the transformation of
the fusion protein between the insoluble and soluble
states, especially when different solubilizing additives were
used. Alternatively, the aggregation problem of the AhR
can be probably overcome by using eukaryotic heterol-
ogous expression systems such as animal or plant cells.
The ability ofsfGFP-AhR to bind to TCDD was proven
by a standard and a competitive ELISA. This last type of
ELISA is mainly used for the detection of very-small
antigens that are difficult to be immobilized on a solid
Fig. 7 TCDD detection by the sfGFP-AhR-based competitive ELISA.
a Optimal concentration of the sfGFP-AhR for the assay was
determined by indirect ELISA using serial logarithmic concentrations
(nM) for incubation in TCDD-pre-coated wells. b Competitive ELISA
was performed on serial logarithmic concentrations (ppt) of free TCDD,
which were incubated with the rabbit-a-TCDD or the sfGFP-AhR (30 nM)
before being transferred into the TCDD-pre-coated wells. The detection
of bound sfGFP-AhR in both types of ELISA was performed using a
rabbit anti-GFP, and both rabbit sera were detected with a goat
anti-rabbit-HRP. The logarithmic fit equation and the accuracy (R2)
are shown next to each curve
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support, hard to purify and composed of a few number
of epitopes, e.g. the haptens [14]. It is usually performed
to quantify TCDD contamination in water, soil and
sediment samples [12]. Despite the fact that anti-TCDD
antibody showed more sensitivity for TCDD in competi-
tive ELISA than the sfGFP-AhR, the detection range of
the sfGFP-AhR was much wider. According to the USA-
Environmental Protection Administration (EPA), the
maximum limits for dioxins in wastewater are set to be
5 pg I-TEQ per liter for new companies and 10 pg
I-TEQ per liter for existing companies. These ranges
which equal 5 to 10 ppt of total dioxins are being
covered by estimated sensitivity range of the proposed
sfGFP-AhR detection system. For enhancing the affinity,
replacing the LBD in the sfGFP-AhR fusion, originated
from human AhR, with the equivalent domain from
mouse or rat AhR can be suggested, because they are
known to have better binding kinetics towards TCDD
[38]. Nevertheless, this sfGFP-AhR-based immunoassay
can be exploited as a method for analyzing large number
of samples, from different sources, for contamination
with TCDD, or any similar compounds. An estimated
value of TCDD content can be attributed to the measured
samples simply by comparing the logarithmic curve fit of
the known concentrations of standard TCDD. Samples
that are determined to be positive in this immunoassay
can undergo congener-specific analyses by HR-GC/MS.
Beside its analytical uses, the fluorescent sfGFP-AhR
fusion can be used as a powerful method for bio-tracing of
TCDD within the cells or tissues in diverse unexploited
areas of research. For example, this bioanalytical method
will surely contribute to a better understanding of the
plant/dioxin relationship and therefore in deciphering
the mechanisms involved in plant responses to dioxin
exposure [45, 46].
Conclusions
In conclusion, dioxin binding domain of the AhR was
produced in a fusion with an enhanced form of the GFP
using an efficient E. coli protein expression system. After
Arginine-refolding and affinity purification, the sfGFP-AhR
fusion protein was able to bind to TCDD using a standard
and competitive ELISA, and the detection limit of free
TCDD in samples could reach very low levels (~10 ppt).
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